Nitric oxide synthase
Nitric-oxide synthase | |||||||||
---|---|---|---|---|---|---|---|---|---|
ExPASy NiceZyme view | | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
Nitric oxide synthase, oxygenase domain | |||||||||
---|---|---|---|---|---|---|---|---|---|
|
Nitric oxide synthases (
NOS catalyzes the reaction:[3]
- 2 L-arginine + 3 NADPH + 3 H+ + 4 O2 2 citrulline +2 nitric oxide + 4 H2O + 3 NADP+
NOS isoforms catalyze other leak and side reactions, such as superoxide production at the expense of NADPH. As such, this stoichiometry is not generally observed, and reflects the three electrons supplied per NO by NADPH.
Eukaryotic NOS isozymes are catalytically self-sufficient. The electron flow is:
Species distribution
Arginine-derived NO synthesis has been identified in mammals, fish, birds, invertebrates, and bacteria., while eNOS is membrane associated. Evidence has been found for NO signaling in plants, but plant genomes are devoid of homologs to the superfamily which generates NO in other kingdoms.
Function
In mammals, the endothelial isoform is the primary signal generator in the control of vascular tone, insulin secretion, and airway tone, is involved in regulation of cardiac function and angiogenesis (growth of new blood vessels). NO produced by eNOS has been shown to be a vasodilator identical to the endothelium-derived relaxing factor produced in response to shear from increased blood flow in arteries. This dilates blood vessels by relaxing smooth muscle in their linings. eNOS is the primary controller of smooth muscle tone. NO activates guanylate cyclase, which induces smooth muscle relaxation by:
- Increased intracellular cGMP, which inhibits calcium entry into the cell, and decreases intracellular calcium concentrations
- Activation of K+ channels, which leads to hyperpolarization and relaxation
- Stimulates a cGMP-dependent protein kinase that activates myosin light chain phosphatase, the enzyme that dephosphorylates myosin light chains, which leads to smooth muscle relaxation.
eNOS plays a critical role in embryonic heart development and morphogenesis of coronary arteries and cardiac valves.[6]
The neuronal isoform is involved in the development of nervous system. It functions as a retrograde neurotransmitter important in long term potentiation and hence is likely to be important in memory and learning. nNOS has many other physiological functions, including regulation of cardiac function and peristalsis and sexual arousal in males and females. An alternatively spliced form of nNOS is a major muscle protein that produces signals in response to calcium release from the SR. nNOS in the heart protects against cardiac arrhythmia induced by myocardial infarction.[7]
The primary receiver for NO produced by eNOS and nNOS is soluble guanylate cyclase, but many secondary targets have been identified. S-nitrosylation appears to be an important mode of action.
The inducible isoform iNOS produces large amounts of NO as a defense mechanism. It is synthesized by many cell types in response to cytokines and is an important factor in the response of the body to attack by parasites, bacterial infection, and tumor growth. It is also the cause of septic shock and may play a role in many diseases with an autoimmune etiology.
NOS signaling is involved in development and in fertilization in vertebrates. It has been implicated in transitions between vegetative and reproductive states in invertebrates, and in differentiation leading to spore formation in slime molds. NO produced by bacterial NOS is protective against oxidative damage.
NOS activity has also been correlated with major depressive episodes (MDEs) in the context of major depressive disorder, in a large case-control treatment study published in mid-2021. 460 patients with a current major depressive episode were compared to 895 healthy patients, and by measuring L-citrulline/L-arginine ratio before and after 3–6 months of antidepressant treatment, results indicate that patients in a major depressive episode have significantly lower NOS activity compared to healthy patients, whilst treatment with antidepressants significantly elevated NOS activity levels in patients in a major depressive episode.[8]
Classification
Different members of the NOS family are encoded by separate genes.[9] There are three known isoforms in mammals, two are constitutive (cNOS) and the third is inducible (iNOS).[10] Cloning of NOS enzymes indicates that cNOS include both brain constitutive (NOS1) and endothelial constitutive (NOS3); the third is the inducible (NOS2) gene.[10] Recently, NOS activity has been demonstrated in several bacterial species, including the notorious pathogens Bacillus anthracis and Staphylococcus aureus.[11]
The different forms of NO synthase have been classified as follows:
Name | Gene(s) | Location | Function |
Neuronal NOS (nNOS or NOS1) | NOS1 (Chromosome 12) |
|
|
Inducible NOS (iNOS or NOS2)
Calcium insensitive |
NOS2 (Chromosome 17) |
|
|
Endothelial NOS (eNOS or NOS3 or cNOS) | NOS3 (Chromosome 7) | ||
Bacterial NOS (bNOS) | multiple |
|
|
nNOS
- Synaptic plasticity in the central nervous system (CNS)
- Smooth muscle relaxation
- Central regulation of blood pressure
- Vasodilatation via peripheral nitrergic nerves
Neuronal NOS also performs a role in cell communication and is associated with plasma membranes. nNOS action can be inhibited by NPA (
The subcellular localisation of nNOS in skeletal muscle is mediated by anchoring of nNOS to dystrophin. nNOS contains an additional N-terminal domain, the PDZ domain.[14]
The gene coding for nNOS is located on Chromosome 12.[15]
iNOS
As opposed to the critical calcium-dependent regulation of constitutive NOS enzymes (nNOS and eNOS), iNOS has been described as calcium-insensitive, likely due to its tight non-covalent interaction with calmodulin (CaM) and Ca2+. The gene coding for iNOS is located on Chromosome 17.
Induction of the high-output iNOS usually occurs in an oxidative environment, and thus high levels of NO have the opportunity to react with superoxide leading to peroxynitrite formation and cell toxicity. These properties may define the roles of iNOS in host immunity, enabling its participation in anti-microbial and anti-tumor activities as part of the oxidative burst of macrophages.[17]
It has been suggested that pathologic generation of
eNOS
Endothelial NOS (eNOS), also known as nitric oxide synthase 3 (NOS3), generates NO in blood vessels and is involved with regulating vascular function. The gene coding for eNOS is located on Chromosome 7.[15] A constitutive Ca2+ dependent NOS provides a basal release of NO. eNOS localizes to caveolae, a plasma membrane domain primarily composed of the protein caveolin 1, and to the Golgi apparatus. These two eNOS populations are distinct, but are both necessary for proper NO production and cell health.[19] eNOS localization to endothelial membranes is mediated by cotranslational N-terminal myristoylation and post-translational palmitoylation.[20]
bNOS
Bacterial NOS (bNOS) has been shown to protect bacteria against oxidative stress, diverse antibiotics, and host immune response. bNOS plays a key role in the transcription of superoxide dismutase (SodA). Bacteria late in the log phase who do not possess bNOS fail to upregulate SodA, which disables the defenses against harmful oxidative stress. Initially, bNOS may have been present to prepare the cell for stressful conditions but now seems to help shield the bacteria against conventional antimicrobials. As a clinical application, a bNOS inhibitor could be produced to decrease the load of Gram positive bacteria.[21][22]
Chemical reaction
Nitric oxide synthases produce NO by catalysing a five-electron oxidation of a guanidino nitrogen of L-arginine (L-Arg). Oxidation of L-Arg to L-citrulline occurs via two successive monooxygenation reactions producing Nω-hydroxy-L-arginine (NOHLA) as an intermediate. 2 mol of O2 and 1.5 mol of NADPH are consumed per mole of NO formed.[3]
Structure
The enzymes exist as homodimers. In eukaryotes, each monomer consisting of two major regions: an N-terminal
NOSs can be
All three
), BH4 activates heme-bound O2 by donating a single electron, which is then recaptured to enable nitric oxide release.The first nitric oxide synthase to be identified was found in neuronal tissue (NOS1 or nNOS); the
In NOS1 and NOS3, physiological concentrations of Ca2+ in cells regulate the binding of calmodulin to the "latch domains", thereby initiating electron transfer from the flavins to the heme moieties. In contrast, calmodulin remains tightly bound to the inducible and Ca2+-insensitive isoform (iNOS or NOS2) even at a low intracellular Ca2+ activity, acting essentially as a subunit of this isoform.
Nitric oxide may itself regulate NOS expression and activity. Specifically, NO has been shown to play an important negative feedback regulatory role on NOS3, and therefore vascular endothelial cell function.[24] This process, known formally as S-nitrosation (and referred to by many in the field as S-nitrosylation), has been shown to reversibly inhibit NOS3 activity in vascular endothelial cells. This process may be important because it is regulated by cellular redox conditions and may thereby provide a mechanism for the association between "oxidative stress" and endothelial dysfunction. In addition to NOS3, both NOS1 and NOS2 have been found to be S-nitrosated, but the evidence for dynamic regulation of those NOS isoforms by this process is less complete[citation needed]. In addition, both NOS1 and NOS2 have been shown to form ferrous-nitrosyl complexes in their heme prosthetic groups that may act partially to self-inactivate these enzymes under certain conditions[citation needed]. The rate-limiting step for the production of nitric oxide may well be the availability of L-arginine in some cell types. This may be particularly important after the induction of NOS2.
Inhibitors
, among others.See also
- Biological functions of nitric oxide
- Nitric-oxide synthase (NAD(P)H-dependent)
- Nitric oxide synthase 2 (inducible)
References
- PMID 21138269.
- PMID 32017079.
- ^ PMID 7510950.
- PMID 25180171.
- )
- PMID 22579300.
- PMID 19770398.
- S2CID 219587961. Retrieved 26 December 2021.
- PMID 9366709.
- ^ PMID 10320659.
- PMID 18316370.
- PMID 21890489.
- PMID 8619882.
- PMID 7535955.
- ^ PMID 7510950.
- PMID 7537721.
- S2CID 26600958.
- PMID 19482272.
- S2CID 212642840.
- PMID 9199168.
- PMID 16172391.
- PMID 19745150.
- PMID 9493011.
- PMID 21753901.
External links
- Nitric+oxide+synthase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- The Nobel Prize in Physiology or Medicine 1998
- University of Edinburgh, School of Chemistry - NO Synthase
- Nitric Oxide Synthase in Proteopedia